Our Story
At Livingsciences, our journey began with a deeply personal and poignant experience. Our founder’s mother bravely battled cancer, and despite her courageous fight, she eventually passed away. Having gone through the experience of struggle, loss, uncertainty, emotional turmoil, and pain which only a patient and family understand, our founder accepted the fact that this disease can happen to anyone at any time.
We believe that having guidance and finding the right treatment at the right time when it happens is crucial - not just to increase the survival rate but the impact on mental and emotional health. Addressing the uncertainty faced during decision-making is equally important for both the patient and family in fighting this through. This effort ignited by our founder is a relentless quest for remedies and ways to help others facing similar battles. Our founders hope that this solution can give assurance, and guidance, remove doubts when we need to make decisions, as well as remove the unnecessary pain and burden which patients and families need to go through during treatment.
Driven by love and dedication, our founder immersed herself in extensive research and exploration of various treatments and holistic approaches. This passion evolved into a mission to create a space where others could find support, resources, and hope in their journey of fighting cancer. Through this endeavor, we aim to honor the memory of our founder’s mother by providing compassionate care, innovative solutions, and a supportive community for those affected by cancer. Our story is one of resilience, hope, and a commitment to making a positive impact in the lives of others.
Livingsciences partners with Invitrocue to offer world-class, innovative life sciences solutions, specializing in developing groundbreaking 3D cell-based models such as Patient-Derived Organoids (PDOs) from solid cancers. Utilizing the Onco-PDO test, we perform in vitro drug screenings on PDOs to provide oncologists with vital information to better direct patient therapy and personalize treatment. Every patient is unique and therefore so is their cancer. By enabling assessment of the treatment efficacy in real-time and on the specific actual patient's own unique cancer organoids, we impact valuable knowledge to the industry, aiding in the decision-making for the right disease treatment for each patient. Our goal is to create a healthier society by providing patients with the best possible care.
In addition to our work in oncology, Livingsciences, through InvitroU, offers cutting-edge epigenetic solutions via DNA methylation services. Our core objective is to provide researchers, physicians, and patients with the most insightful well-being analysis from a lab that is both CLIA-certified and PDPA-compliant. InvitroU’s MyTruHealth and MyTruAge DNA methylation testing services enable the analysis of DNA methylation patterns to determine an individual's aging, immunity, chronic disease risk, as well as early detection through the evaluation of multi-omics which includes level of evaluation through genomics, proteomics, metabolites, clinical factors and many more. Our test readouts will continue to expand and cover more and more aspects of life each day. Additionally, we offer comprehensive metrics related to aging, including the pace of aging, immune age, and the risk of chronic diseases. Our test readouts continue to expand, covering more aspects of life each day.
At Livingsciences, we are committed to transforming the future of healthcare through innovation, compassion, and a relentless pursuit of excellence. Our founder’s journey inspires us daily to strive for breakthroughs that will make a lasting impact on the lives of patients and their families.
